The job description provides a comprehensive overview of the role and the organization, but it could benefit from improved formatting and clearer separation of sections for better readability. It currently contains large blocks of text that could be broken down into more digestible parts.
Here's a refined version with better use of HTML tags:
Social network you want to login/join with:
The post will require the applicant to co-ordinate and support the molecular radiotherapy pathway in the Radiotherapy and Nuclear Medicine department at UCLH. Both practices are large and innovative, with an expanding paediatric, teenagers, young adults, and adult workload. Some research and data inputting may be required.
About the Institute of Nuclear Medicine (INM):
Based within UCLH, INM provides a full range of procedures to the Trust and other hospitals throughout the UK. Performing approximately 15,000 patient studies each year, it is the largest single-site nuclear medicine unit in the UK, offering diagnostic, laboratory, therapy nuclear medicine procedures, and PET/CT services within a single department.
Molecular radiotherapy offered at UCLH includes:
Ten protected rooms are provided in the building, six of which are in regular clinical use.
Candidate profile:
UCLH is seeking a committed individual with the energy and focus to continue building on the existing service of excellence and to lead in their area of expertise.
Main duties of the job:
Working for our organization:
UCLH is a complex NHS trust serving a diverse population, providing acute and specialist services with a focus on quality patient care, education, and research.
Our services span across eight sites, including:
We are dedicated to treating complex illnesses, with specialties including women's health, cancer, infection, neurological, gastrointestinal, and oral diseases. Our support services include critical care, imaging, nuclear medicine, and pathology.
UCLH is committed to sustainability, aiming for a carbon net zero health service by 2031 for direct emissions and by 2040 for indirect emissions.